CPX-351

Vyxeos

Treatment Description

CPX-351 is a drug that combines cytarabine and daunorubicin, and is approved for the treatment of acute myeloma leukemia. It is currently being studied for use in several other cancers.

Participating Centers

There are 8 centers running trials with this treatment. Enter a location below to find the closest center.